Request for Covid-19 Impact Assessment of this Report
The United States Pet NSAIDs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pet NSAIDs market, reaching US$ million by the year 2028. As for the Europe Pet NSAIDs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Pet NSAIDs players cover Zoetis, Elanco, PREVICOX, and Metacam, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet NSAIDs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Carprofen
Deracoxib
Firocoxib
Meloxicam
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Dog
Cat
Horse
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Zoetis
Elanco
PREVICOX
Metacam
Chanelle Pharma
AVENTIX
Woodruff
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
Vethical
Vetoquinol
Pivetal
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet NSAIDs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet NSAIDs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet NSAIDs by Country/Region, 2017, 2022 & 2028
2.2 Pet NSAIDs Segment by Type
2.2.1 Carprofen
2.2.2 Deracoxib
2.2.3 Firocoxib
2.2.4 Meloxicam
2.3 Pet NSAIDs Sales by Type
2.3.1 Global Pet NSAIDs Sales Market Share by Type (2017-2022)
2.3.2 Global Pet NSAIDs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet NSAIDs Sale Price by Type (2017-2022)
2.4 Pet NSAIDs Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Horse
2.4.4 Others
2.5 Pet NSAIDs Sales by Application
2.5.1 Global Pet NSAIDs Sale Market Share by Application (2017-2022)
2.5.2 Global Pet NSAIDs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet NSAIDs Sale Price by Application (2017-2022)
3 Global Pet NSAIDs by Company
3.1 Global Pet NSAIDs Breakdown Data by Company
3.1.1 Global Pet NSAIDs Annual Sales by Company (2020-2022)
3.1.2 Global Pet NSAIDs Sales Market Share by Company (2020-2022)
3.2 Global Pet NSAIDs Annual Revenue by Company (2020-2022)
3.2.1 Global Pet NSAIDs Revenue by Company (2020-2022)
3.2.2 Global Pet NSAIDs Revenue Market Share by Company (2020-2022)
3.3 Global Pet NSAIDs Sale Price by Company
3.4 Key Manufacturers Pet NSAIDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet NSAIDs Product Location Distribution
3.4.2 Players Pet NSAIDs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet NSAIDs by Geographic Region
4.1 World Historic Pet NSAIDs Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet NSAIDs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet NSAIDs Annual Revenue by Geographic Region
4.2 World Historic Pet NSAIDs Market Size by Country/Region (2017-2022)
4.2.1 Global Pet NSAIDs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet NSAIDs Annual Revenue by Country/Region
4.3 Americas Pet NSAIDs Sales Growth
4.4 APAC Pet NSAIDs Sales Growth
4.5 Europe Pet NSAIDs Sales Growth
4.6 Middle East & Africa Pet NSAIDs Sales Growth
5 Americas
5.1 Americas Pet NSAIDs Sales by Country
5.1.1 Americas Pet NSAIDs Sales by Country (2017-2022)
5.1.2 Americas Pet NSAIDs Revenue by Country (2017-2022)
5.2 Americas Pet NSAIDs Sales by Type
5.3 Americas Pet NSAIDs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet NSAIDs Sales by Region
6.1.1 APAC Pet NSAIDs Sales by Region (2017-2022)
6.1.2 APAC Pet NSAIDs Revenue by Region (2017-2022)
6.2 APAC Pet NSAIDs Sales by Type
6.3 APAC Pet NSAIDs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet NSAIDs by Country
7.1.1 Europe Pet NSAIDs Sales by Country (2017-2022)
7.1.2 Europe Pet NSAIDs Revenue by Country (2017-2022)
7.2 Europe Pet NSAIDs Sales by Type
7.3 Europe Pet NSAIDs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet NSAIDs by Country
8.1.1 Middle East & Africa Pet NSAIDs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet NSAIDs Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet NSAIDs Sales by Type
8.3 Middle East & Africa Pet NSAIDs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet NSAIDs
10.3 Manufacturing Process Analysis of Pet NSAIDs
10.4 Industry Chain Structure of Pet NSAIDs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet NSAIDs Distributors
11.3 Pet NSAIDs Customer
12 World Forecast Review for Pet NSAIDs by Geographic Region
12.1 Global Pet NSAIDs Market Size Forecast by Region
12.1.1 Global Pet NSAIDs Forecast by Region (2023-2028)
12.1.2 Global Pet NSAIDs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet NSAIDs Forecast by Type
12.7 Global Pet NSAIDs Forecast by Application
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Pet NSAIDs Product Offered
13.1.3 Zoetis Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Pet NSAIDs Product Offered
13.2.3 Elanco Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 PREVICOX
13.3.1 PREVICOX Company Information
13.3.2 PREVICOX Pet NSAIDs Product Offered
13.3.3 PREVICOX Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 PREVICOX Main Business Overview
13.3.5 PREVICOX Latest Developments
13.4 Metacam
13.4.1 Metacam Company Information
13.4.2 Metacam Pet NSAIDs Product Offered
13.4.3 Metacam Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Metacam Main Business Overview
13.4.5 Metacam Latest Developments
13.5 Chanelle Pharma
13.5.1 Chanelle Pharma Company Information
13.5.2 Chanelle Pharma Pet NSAIDs Product Offered
13.5.3 Chanelle Pharma Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Chanelle Pharma Main Business Overview
13.5.5 Chanelle Pharma Latest Developments
13.6 AVENTIX
13.6.1 AVENTIX Company Information
13.6.2 AVENTIX Pet NSAIDs Product Offered
13.6.3 AVENTIX Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AVENTIX Main Business Overview
13.6.5 AVENTIX Latest Developments
13.7 Woodruff
13.7.1 Woodruff Company Information
13.7.2 Woodruff Pet NSAIDs Product Offered
13.7.3 Woodruff Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Woodruff Main Business Overview
13.7.5 Woodruff Latest Developments
13.8 KRKA UK Ltd
13.8.1 KRKA UK Ltd Company Information
13.8.2 KRKA UK Ltd Pet NSAIDs Product Offered
13.8.3 KRKA UK Ltd Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 KRKA UK Ltd Main Business Overview
13.8.5 KRKA UK Ltd Latest Developments
13.9 Dechra
13.9.1 Dechra Company Information
13.9.2 Dechra Pet NSAIDs Product Offered
13.9.3 Dechra Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Dechra Main Business Overview
13.9.5 Dechra Latest Developments
13.10 Parnell
13.10.1 Parnell Company Information
13.10.2 Parnell Pet NSAIDs Product Offered
13.10.3 Parnell Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Parnell Main Business Overview
13.10.5 Parnell Latest Developments
13.11 VetUK
13.11.1 VetUK Company Information
13.11.2 VetUK Pet NSAIDs Product Offered
13.11.3 VetUK Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 VetUK Main Business Overview
13.11.5 VetUK Latest Developments
13.12 Norbrook
13.12.1 Norbrook Company Information
13.12.2 Norbrook Pet NSAIDs Product Offered
13.12.3 Norbrook Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Norbrook Main Business Overview
13.12.5 Norbrook Latest Developments
13.13 Alivira Animal Health
13.13.1 Alivira Animal Health Company Information
13.13.2 Alivira Animal Health Pet NSAIDs Product Offered
13.13.3 Alivira Animal Health Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Alivira Animal Health Main Business Overview
13.13.5 Alivira Animal Health Latest Developments
13.14 Vedco Inc
13.14.1 Vedco Inc Company Information
13.14.2 Vedco Inc Pet NSAIDs Product Offered
13.14.3 Vedco Inc Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Vedco Inc Main Business Overview
13.14.5 Vedco Inc Latest Developments
13.15 Vethical
13.15.1 Vethical Company Information
13.15.2 Vethical Pet NSAIDs Product Offered
13.15.3 Vethical Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Vethical Main Business Overview
13.15.5 Vethical Latest Developments
13.16 Vetoquinol
13.16.1 Vetoquinol Company Information
13.16.2 Vetoquinol Pet NSAIDs Product Offered
13.16.3 Vetoquinol Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Vetoquinol Main Business Overview
13.16.5 Vetoquinol Latest Developments
13.17 Pivetal
13.17.1 Pivetal Company Information
13.17.2 Pivetal Pet NSAIDs Product Offered
13.17.3 Pivetal Pet NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Pivetal Main Business Overview
13.17.5 Pivetal Latest Developments
14 Research Findings and Conclusion
Table 1. Pet NSAIDs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet NSAIDs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Carprofen
Table 4. Major Players of Deracoxib
Table 5. Major Players of Firocoxib
Table 6. Major Players of Meloxicam
Table 7. Global Pet NSAIDs Sales by Type (2017-2022) & (K Units)
Table 8. Global Pet NSAIDs Sales Market Share by Type (2017-2022)
Table 9. Global Pet NSAIDs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Pet NSAIDs Revenue Market Share by Type (2017-2022)
Table 11. Global Pet NSAIDs Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Pet NSAIDs Sales by Application (2017-2022) & (K Units)
Table 13. Global Pet NSAIDs Sales Market Share by Application (2017-2022)
Table 14. Global Pet NSAIDs Revenue by Application (2017-2022)
Table 15. Global Pet NSAIDs Revenue Market Share by Application (2017-2022)
Table 16. Global Pet NSAIDs Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Pet NSAIDs Sales by Company (2020-2022) & (K Units)
Table 18. Global Pet NSAIDs Sales Market Share by Company (2020-2022)
Table 19. Global Pet NSAIDs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Pet NSAIDs Revenue Market Share by Company (2020-2022)
Table 21. Global Pet NSAIDs Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Pet NSAIDs Producing Area Distribution and Sales Area
Table 23. Players Pet NSAIDs Products Offered
Table 24. Pet NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pet NSAIDs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Pet NSAIDs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Pet NSAIDs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Pet NSAIDs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Pet NSAIDs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Pet NSAIDs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Pet NSAIDs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Pet NSAIDs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Pet NSAIDs Sales by Country (2017-2022) & (K Units)
Table 36. Americas Pet NSAIDs Sales Market Share by Country (2017-2022)
Table 37. Americas Pet NSAIDs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Pet NSAIDs Revenue Market Share by Country (2017-2022)
Table 39. Americas Pet NSAIDs Sales by Type (2017-2022) & (K Units)
Table 40. Americas Pet NSAIDs Sales Market Share by Type (2017-2022)
Table 41. Americas Pet NSAIDs Sales by Application (2017-2022) & (K Units)
Table 42. Americas Pet NSAIDs Sales Market Share by Application (2017-2022)
Table 43. APAC Pet NSAIDs Sales by Region (2017-2022) & (K Units)
Table 44. APAC Pet NSAIDs Sales Market Share by Region (2017-2022)
Table 45. APAC Pet NSAIDs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Pet NSAIDs Revenue Market Share by Region (2017-2022)
Table 47. APAC Pet NSAIDs Sales by Type (2017-2022) & (K Units)
Table 48. APAC Pet NSAIDs Sales Market Share by Type (2017-2022)
Table 49. APAC Pet NSAIDs Sales by Application (2017-2022) & (K Units)
Table 50. APAC Pet NSAIDs Sales Market Share by Application (2017-2022)
Table 51. Europe Pet NSAIDs Sales by Country (2017-2022) & (K Units)
Table 52. Europe Pet NSAIDs Sales Market Share by Country (2017-2022)
Table 53. Europe Pet NSAIDs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Pet NSAIDs Revenue Market Share by Country (2017-2022)
Table 55. Europe Pet NSAIDs Sales by Type (2017-2022) & (K Units)
Table 56. Europe Pet NSAIDs Sales Market Share by Type (2017-2022)
Table 57. Europe Pet NSAIDs Sales by Application (2017-2022) & (K Units)
Table 58. Europe Pet NSAIDs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Pet NSAIDs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Pet NSAIDs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pet NSAIDs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Pet NSAIDs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Pet NSAIDs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Pet NSAIDs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Pet NSAIDs Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Pet NSAIDs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Pet NSAIDs
Table 68. Key Market Challenges & Risks of Pet NSAIDs
Table 69. Key Industry Trends of Pet NSAIDs
Table 70. Pet NSAIDs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Pet NSAIDs Distributors List
Table 73. Pet NSAIDs Customer List
Table 74. Global Pet NSAIDs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Pet NSAIDs Sales Market Forecast by Region
Table 76. Global Pet NSAIDs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Pet NSAIDs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Pet NSAIDs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Pet NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Pet NSAIDs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Pet NSAIDs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Pet NSAIDs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Pet NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Pet NSAIDs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Pet NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Pet NSAIDs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Pet NSAIDs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Pet NSAIDs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Pet NSAIDs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Pet NSAIDs Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Pet NSAIDs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Pet NSAIDs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Pet NSAIDs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Zoetis Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 95. Zoetis Pet NSAIDs Product Offered
Table 96. Zoetis Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Zoetis Main Business
Table 98. Zoetis Latest Developments
Table 99. Elanco Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 100. Elanco Pet NSAIDs Product Offered
Table 101. Elanco Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Elanco Main Business
Table 103. Elanco Latest Developments
Table 104. PREVICOX Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 105. PREVICOX Pet NSAIDs Product Offered
Table 106. PREVICOX Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. PREVICOX Main Business
Table 108. PREVICOX Latest Developments
Table 109. Metacam Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 110. Metacam Pet NSAIDs Product Offered
Table 111. Metacam Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Metacam Main Business
Table 113. Metacam Latest Developments
Table 114. Chanelle Pharma Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 115. Chanelle Pharma Pet NSAIDs Product Offered
Table 116. Chanelle Pharma Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Chanelle Pharma Main Business
Table 118. Chanelle Pharma Latest Developments
Table 119. AVENTIX Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 120. AVENTIX Pet NSAIDs Product Offered
Table 121. AVENTIX Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. AVENTIX Main Business
Table 123. AVENTIX Latest Developments
Table 124. Woodruff Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 125. Woodruff Pet NSAIDs Product Offered
Table 126. Woodruff Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Woodruff Main Business
Table 128. Woodruff Latest Developments
Table 129. KRKA UK Ltd Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 130. KRKA UK Ltd Pet NSAIDs Product Offered
Table 131. KRKA UK Ltd Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. KRKA UK Ltd Main Business
Table 133. KRKA UK Ltd Latest Developments
Table 134. Dechra Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 135. Dechra Pet NSAIDs Product Offered
Table 136. Dechra Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Dechra Main Business
Table 138. Dechra Latest Developments
Table 139. Parnell Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 140. Parnell Pet NSAIDs Product Offered
Table 141. Parnell Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Parnell Main Business
Table 143. Parnell Latest Developments
Table 144. VetUK Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 145. VetUK Pet NSAIDs Product Offered
Table 146. VetUK Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. VetUK Main Business
Table 148. VetUK Latest Developments
Table 149. Norbrook Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 150. Norbrook Pet NSAIDs Product Offered
Table 151. Norbrook Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Norbrook Main Business
Table 153. Norbrook Latest Developments
Table 154. Alivira Animal Health Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 155. Alivira Animal Health Pet NSAIDs Product Offered
Table 156. Alivira Animal Health Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Alivira Animal Health Main Business
Table 158. Alivira Animal Health Latest Developments
Table 159. Vedco Inc Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 160. Vedco Inc Pet NSAIDs Product Offered
Table 161. Vedco Inc Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Vedco Inc Main Business
Table 163. Vedco Inc Latest Developments
Table 164. Vethical Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 165. Vethical Pet NSAIDs Product Offered
Table 166. Vethical Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. Vethical Main Business
Table 168. Vethical Latest Developments
Table 169. Vetoquinol Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 170. Vetoquinol Pet NSAIDs Product Offered
Table 171. Vetoquinol Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 172. Vetoquinol Main Business
Table 173. Vetoquinol Latest Developments
Table 174. Pivetal Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 175. Pivetal Pet NSAIDs Product Offered
Table 176. Pivetal Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 177. Pivetal Main Business
Table 178. Pivetal Latest Developments
List of Figures
Figure 1. Picture of Pet NSAIDs
Figure 2. Pet NSAIDs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet NSAIDs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pet NSAIDs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet NSAIDs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Carprofen
Figure 10. Product Picture of Deracoxib
Figure 11. Product Picture of Firocoxib
Figure 12. Product Picture of Meloxicam
Figure 13. Global Pet NSAIDs Sales Market Share by Type in 2021
Figure 14. Global Pet NSAIDs Revenue Market Share by Type (2017-2022)
Figure 15. Pet NSAIDs Consumed in Dog
Figure 16. Global Pet NSAIDs Market: Dog (2017-2022) & (K Units)
Figure 17. Pet NSAIDs Consumed in Cat
Figure 18. Global Pet NSAIDs Market: Cat (2017-2022) & (K Units)
Figure 19. Pet NSAIDs Consumed in Horse
Figure 20. Global Pet NSAIDs Market: Horse (2017-2022) & (K Units)
Figure 21. Pet NSAIDs Consumed in Others
Figure 22. Global Pet NSAIDs Market: Others (2017-2022) & (K Units)
Figure 23. Global Pet NSAIDs Sales Market Share by Application (2017-2022)
Figure 24. Global Pet NSAIDs Revenue Market Share by Application in 2021
Figure 25. Pet NSAIDs Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Pet NSAIDs Revenue Market Share by Company in 2021
Figure 27. Global Pet NSAIDs Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Pet NSAIDs Revenue Market Share by Geographic Region in 2021
Figure 29. Global Pet NSAIDs Sales Market Share by Region (2017-2022)
Figure 30. Global Pet NSAIDs Revenue Market Share by Country/Region in 2021
Figure 31. Americas Pet NSAIDs Sales 2017-2022 (K Units)
Figure 32. Americas Pet NSAIDs Revenue 2017-2022 ($ Millions)
Figure 33. APAC Pet NSAIDs Sales 2017-2022 (K Units)
Figure 34. APAC Pet NSAIDs Revenue 2017-2022 ($ Millions)
Figure 35. Europe Pet NSAIDs Sales 2017-2022 (K Units)
Figure 36. Europe Pet NSAIDs Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Pet NSAIDs Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Pet NSAIDs Revenue 2017-2022 ($ Millions)
Figure 39. Americas Pet NSAIDs Sales Market Share by Country in 2021
Figure 40. Americas Pet NSAIDs Revenue Market Share by Country in 2021
Figure 41. United States Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Pet NSAIDs Sales Market Share by Region in 2021
Figure 46. APAC Pet NSAIDs Revenue Market Share by Regions in 2021
Figure 47. China Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Pet NSAIDs Sales Market Share by Country in 2021
Figure 54. Europe Pet NSAIDs Revenue Market Share by Country in 2021
Figure 55. Germany Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Pet NSAIDs Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Pet NSAIDs Revenue Market Share by Country in 2021
Figure 62. Egypt Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Pet NSAIDs Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Pet NSAIDs in 2021
Figure 68. Manufacturing Process Analysis of Pet NSAIDs
Figure 69. Industry Chain Structure of Pet NSAIDs
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...